93 related articles for article (PubMed ID: 35224957)
1. Anesthetic considerations in COVID-associated mucormycosis in a patient with autoimmune disorders.
Rath A; Reena R; Jose S
Minerva Anestesiol; 2022; 88(1-2):87-88. PubMed ID: 35224957
[No Abstract] [Full Text] [Related]
2. Palatal mucormycosis in a patient with SARS-CoV-2 infection.
Venugopal A; Marya A
CMAJ; 2021 Aug; 193(32):E1254. PubMed ID: 34400485
[No Abstract] [Full Text] [Related]
3. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19).
Karimi-Galougahi M; Arastou S; Haseli S
Int Forum Allergy Rhinol; 2021 Jun; 11(6):1029-1030. PubMed ID: 33713565
[No Abstract] [Full Text] [Related]
4. Should statins be considered for the management of mucormycosis in COVID-19?
Chatterjee S; Vardhan B; Singh DK; Maitra A; Ojha UK
Diabetes Metab Syndr; 2021; 15(4):102162. PubMed ID: 34186353
[No Abstract] [Full Text] [Related]
5. Mucormycosis-Related Vision Loss in COVID-19.
Dhoot SK
Ophthalmic Surg Lasers Imaging Retina; 2022 Mar; 53(3):173-174. PubMed ID: 35272556
[No Abstract] [Full Text] [Related]
6. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
[TBL] [Abstract][Full Text] [Related]
7. Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla.
Ingle Y; Sarode SC; Sarode G; Ingle M; Ingle S
Oral Oncol; 2022 Feb; 125():105712. PubMed ID: 35016140
[No Abstract] [Full Text] [Related]
8. Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature.
Ostovan VR; Rezapanah S; Behzadi Z; Hosseini L; Jahangiri R; Anbardar MH; Rostami M
J Neurovirol; 2021 Aug; 27(4):644-649. PubMed ID: 34342852
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
10. CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review.
Garg M; Prabhakar N; Muthu V; Farookh S; Kaur H; Suri V; Agarwal R
Radiology; 2022 Jan; 302(1):214-217. PubMed ID: 34463553
[No Abstract] [Full Text] [Related]
11. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding.
Sarkar S; Gokhale T; Kaliaperumal S; Singh R; Begam RB; Deb AK
Indian J Ophthalmol; 2021 Sep; 69(9):2535-2537. PubMed ID: 34427262
[TBL] [Abstract][Full Text] [Related]
12. Rhino-orbital mucormycosis in a COVID-19 patient.
Baskar HC; Chandran A; Reddy CS; Singh S
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167998
[No Abstract] [Full Text] [Related]
13. Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
Devnath P; Dhama K; Tareq AM; Emran TB
Int J Surg; 2021 Aug; 92():106031. PubMed ID: 34311126
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2, the autoimmune virus.
Halpert G; Shoenfeld Y
Autoimmun Rev; 2020 Dec; 19(12):102695. PubMed ID: 33130000
[No Abstract] [Full Text] [Related]
15. Mucormycosis in head and neck area - the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner.
Pasternak M; Olszanecki R
Folia Med Cracov; 2021; 61(2):117-127. PubMed ID: 34510169
[TBL] [Abstract][Full Text] [Related]
16. Mucormycosis with Severe Acute Respiratory Syndrome Coronavirus-2 Patients on Hemodialysis: A Case Series with Review of Literature.
Dabas A; Swarnim S; Sagar T; Mantan M
Saudi J Kidney Dis Transpl; 2021; 32(4):1152-1157. PubMed ID: 35229816
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated rhino-orbital mucormycosis: a single-centre experience of 10 cases.
Arjun R; Felix V; Niyas VKM; Kumar MAS; Krishnan RB; Mohan V; Ansar A; Gautaam S; Lalitha S
QJM; 2022 Jan; 114(11):831-834. PubMed ID: 34181023
[No Abstract] [Full Text] [Related]
18. Initial and ongoing challenges with COVID-19-associated mucormycosis.
Sikka K; Goel G; Sharma N; Thakar A
Indian J Ophthalmol; 2021 Dec; 69(12):3391-3393. PubMed ID: 34826965
[No Abstract] [Full Text] [Related]
19. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths.
Soman R; Sunavala A
J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431262
[No Abstract] [Full Text] [Related]
20. Mixed mold infection with
Bellanger AP; Navellou JC; Lepiller Q; Brion A; Brunel AS; Millon L; Berceanu A
Infect Dis Now; 2021 Oct; 51(7):633-635. PubMed ID: 33527098
[No Abstract] [Full Text] [Related]
[Next] [New Search]
